Population pharmacokinetics of buprenorphine and naloxone sublingual combination in Chinese healthy volunteers and patients with opioid use disorder: Model-based dose optimization

The sublingual combination of buprenorphine (BUP) and naloxone (NLX) is a new treatment option for opioid use disorder (OUD) and is effective in preventing drug abuse. This study aimed to explore rational dosing regimen for OUD patients in China via a model-based dose optimization approach. BUP, nor...

Descripción completa

Detalles Bibliográficos
Autores principales: Gu, Meng, Li, Anning, Mak, Wenyao, Dong, Fang, Xu, Nuo, Zhang, Jingye, Shi, Yufei, Zheng, Nan, Tang, Zhijia, He, Qingfeng, Ruan, Canjun, Guo, Wei, Xiang, Xiaoqiang, Wang, Chuanyue, Han, Bing, Zhu, Xiao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9893638/
https://www.ncbi.nlm.nih.gov/pubmed/36744255
http://dx.doi.org/10.3389/fphar.2023.1089862

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9893638/
https://www.ncbi.nlm.nih.gov/pubmed/36744255
http://dx.doi.org/10.3389/fphar.2023.1089862

Ejemplares similares